6,497 Shares of VanEck Pharmaceutical ETF $PPH Bought by Leuthold Group LLC

Leuthold Group LLC purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,497 shares of the company’s stock, valued at approximately $711,000. Leuthold Group LLC owned 0.07% of VanEck Pharmaceutical ETF at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Royal Bank of Canada raised its position in shares of VanEck Pharmaceutical ETF by 846.9% during the 1st quarter. Royal Bank of Canada now owns 361,001 shares of the company’s stock worth $37,501,000 after acquiring an additional 322,878 shares in the last quarter. Bank of America Corp DE lifted its stake in VanEck Pharmaceutical ETF by 139.3% during the first quarter. Bank of America Corp DE now owns 143,609 shares of the company’s stock worth $14,918,000 after purchasing an additional 83,598 shares during the last quarter. Fluent Financial LLC acquired a new position in VanEck Pharmaceutical ETF in the second quarter valued at approximately $4,264,000. Avior Wealth Management LLC acquired a new position in VanEck Pharmaceutical ETF in the third quarter valued at approximately $1,685,000. Finally, Commonwealth Equity Services LLC acquired a new position in VanEck Pharmaceutical ETF in the third quarter valued at approximately $1,171,000.

VanEck Pharmaceutical ETF Stock Up 0.3%

Shares of VanEck Pharmaceutical ETF stock opened at $121.58 on Wednesday. The firm has a market capitalization of $1.12 billion, a P/E ratio of 29.81 and a beta of 0.42. VanEck Pharmaceutical ETF has a 52 week low of $95.90 and a 52 week high of $123.53. The firm’s 50 day moving average is $113.25 and its two-hundred day moving average is $108.46.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, October 6th. Stockholders of record on Thursday, October 1st were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Thursday, October 1st. This is a negative change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.